Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients

• Status: Recruiting
• Trial end date: 2024-02-28
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to determine the efficacy of montelukast in reducing the incidence of dengue warning signs in adult dengue patients.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Phramongkutklao College of Medicine and Hospital
• Treatments: Montelukast

Criteria

Inclusion Criteria:

• at least 18 years old

• diagnosis of dengue

• positive NS1 antigen or polymerase chain reaction (PCR) test

Exclusion Criteria:

• any warning sign of dengue

• concurrent diagnosis of other causes of fever, such as malaria or heat stroke

• pregnancy

• being unable to take medication by mouth

• critical illness needing intubation or admission to an intensive care unit

• being unable to communicate

• other indication of montelukast